Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech Harvard Case Solution & Analysis

In 2001, Vertex Pharmaceuticals has acquired United San Diego biotech company, Aurora Biosciences. The combination of Vertex and Technology Aurora would improve the flow of new drug candidates in development. However, some issues related to the integration in Aurora Vertex has not been resolved, the most relevant are major collaboration with Aurora CF Foundation (CFF). Were venture philanthropy and foundation deals appropriate funding mechanism for public companies like Vertex? How could the Board of Vertex and CFF fundamentally agree on the objectives of a commercial company with the non-profit organization? These were the questions faced by managers Vertex. "Hide
by Robert F. Higgins, Brent Kazan Source: Harvard Business School 27 pages. Publication Date: October 15, 2007. Prod. #: 808005-PDF-ENG

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech Case Solution Other Similar Case Solutions like

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

Share This